<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>12</Volume><Issue>6</Issue><PubDate PubStatus="epublish"><Year>2021</Year><Month>10</Month><Day>13</Day></PubDate></Journal><title locale="en_US">Challenges of the Health System in Preventing Non‑Communicable  Diseases; Systematized Review</title><FirstPage>2483</FirstPage><LastPage>2483</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Health Services  Management, Student Research  Committee, School of Management  and Medical Information  Sciences, Health Management  and Economics Research Center,  Isfahan University of Medical  Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Australasian Nanoscience and  Nanotechnology Initiative (ANNI),  8054 Monash University LPO,  Clayton, Victoria 3168, Australia &amp; Supreme NanoBiotics Co. Ltd.  and Supreme Pharmatech Co. Ltd.,  399/90-95 Moo 13 Kingkaew Rd.  Soi 25/1, T. Rachateva, A. Bangplee, &#13;
Samutprakan 10540, Thailand</affiliation></Author><Author><affiliation locale="en_US">Department of Medical  Library and Information Sciences,  Health Information Technology  Research Center, Student Research  Committee, School of Management  and Medical Information Sciences,  Isfahan University of Medical  Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Department of Health  Services Management, Health  Management and Economics  Research Center, Isfahan University  of Medical Sciences, Isfahan</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>13</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;: The basis of prevention of non‑communicable diseases is the identification of primary risk factors and the prevention and control of these factors. The purpose is to prevent the spread of the disease and to control it as much as possible. If population growth continues at this rate, by 2030, 52 million people will die from these diseases each year. The aim of this study was to evaluate the challenges of preventing non‑communicable diseases.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;: The present study was a systematic review that conducted in July 2020 and the articles related to prevention of non‑communicable diseases on databases of web of science, PubMed, Scopus, science direct, Ovid, Pro Quest and Google Scholar. Strategy for searching and selecting the articles was PRISMA Guidelines.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;: Challenges of non‑communicable disease prevention, in 4 main codes, including infrastructure, economic, demographic and management and 12 sub‑codes that include, lack of preventive infrastructure, restrictions on access to medicine, restrictions on primary health care, restrictions on access to Technology, disease‑oriented disease, unsustainable financial resources, failure to implement poverty reduction projects, increase in aging population, migration, rapid and unplanned urban planning, hasty planning and lack of internal and external coordination were classified.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: To reduce non‑communicable diseases, strengthen global capacities, reduce risk factors for NCDs and place social determinants by creating health‑promoting environments, strengthen health systems to implement prevention and control of NCDs, and place determinants Social can play an effective role through people‑centered primary health care&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2483</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2483/717718323</pdf_url></Article></Articles>
